HIV Diagnostics

HIV Testing

HIV remains a major global public health challenge. Over more than 40 years of scientific and clinical progress, HIV infection has evolved from a fatal disease into a manageable chronic condition. However, achieving the global goal of ending the HIV epidemic will require continued advances in early detection and precision disease management.

Learn More

Powered by Supbio’s proprietary Microscale-Precision Technologies, the company has developed the world’s first HIV-1 DNA quantitative detection kit, addressing a critical unmet need in HIV diagnostics. This breakthrough provides a powerful tool for early detection, treatment evaluation, and HIV cure research, helping move HIV management toward a new era of comprehensive precision monitoring.

Ordering Information

Intended Use

Performance Characteristic

Catalog Number

SUPI-1103

Package Size

48 Tests / Kit

Intended Use

This kit is intended for the in vitro quantitative detection of Human Immunodeficiency Virus Type 1 (HIV-1), Group M DNA, in human whole blood.

High sensitivity and specificity with broad compatibility across major qPCR platforms. No additional or dedicated instrumentation is required, enabling true plug-and-play implementation.

Human Immunodeficiency Virus Type 1 (HIV-1) DNA Detection Kit （qPCR）

Catalog Number

Package Size

Intended Use

Authoritative Recognition and Industry Influence